Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

34.22
-0.4540-1.31%
Volume:936
Turnover:32.13K
Market Cap:43.62M
PE:- -
High:34.39
Open:34.39
Low:34.22
Close:34.67
52wk High:35.61
52wk Low:27.50
Shares:1.28M
Float Shares:1.28M
Volume Ratio:0.90
T/O Rate:0.07%
Dividend:0.08
Dividend Rate:0.22%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novo Begins Study to Find Lowest Effective Dose for Wegovy Pill

Reuters
·
Aug 19

The Key to Pharma M&A: Never Shopping Hungry - Heard on the Street

Dow Jones
·
Aug 19

Legend Biotech (LEGN) Turns Profitable In Q2, Is The Stock Cheap?

Simply Wall St.
·
Aug 19

What This Top Biotech Fund is Buying Now

Dow Jones
·
Aug 19

Ascendis Pharma Director Jean-Jacques Bienaime Buys USD 492,079 of Common Shares

Reuters
·
Aug 19

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Disposes of USD 3.86 Million in Common Shares

Reuters
·
Aug 19

Rhythm Pharma Files Form 3 for Chief Medical Officer Manher Joshi

Reuters
·
Aug 19

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 19

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 19

BMO starts Exelixis at Market Perform into patent cliff

TIPRANKS
·
Aug 19

Legend Biotech Sets September 24, 2026 AGM With Expanded Equity Plan on Agenda

TIPRANKS
·
Aug 19

Eli Lilly EVP, International President Patrik Jonsson Disposes of 6,500 Shares Worth $7.64 Million

Reuters
·
Aug 19

Legend Biotech Seeks Shareholder OK to Add 19.1 Million Shares to RSU Plan Reserve

Reuters
·
Aug 19

Legend Biotech Announces Annual General Meeting

Reuters
·
Aug 19

Eli Lilly and Co Stock (LLY) Moved Up by 3.19% on Aug 18: What Signal Does It Send?

TradingKey
·
Aug 19

Gilead Sciences Inc Stock (GILD) Moved Up by 3.14% on Aug 18: Drivers Behind the Movement

TradingKey
·
Aug 19

Eli Lilly (LLY) Stock Looks Undervalued Relative To Fair Value

Simply Wall St.
·
Aug 19

Amylyx Phase 3 data support FDA approval, says Citi

TIPRANKS
·
Aug 18

Eyconis Announces Initiation of First-in-Human Clinical Trial of Eyc-0305 in Treatment-NaÏVe Wet Age-Related Macular Degeneration Patients

THOMSON REUTERS
·
Aug 18

Eli Lilly Pays $10 Million Upfront to AlzeCure Under Alzstatin Deal

MT Newswires Live
·
Aug 18